TOPISCHE FORMULIERUNG MIT SIROLIMUS

European patent · EP4228598 · In force

Register entry

Publication number
EP4228598
Application number
EP22702492
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Feb 9, 2022
Published
Aug 23, 2023
Granted
Dec 27, 2023
Protection ends at the latest
Feb 8, 2042
Next annual fee due
Feb 28, 2027
IPC classes
A61K 9/06 (2006.01)
A61K 9/14 (2006.01)
A61K 31/436 (2006.01)
A61P 17/00 (2006.01)
A61P 35/00 (2006.01)
A61K 47/10 (2017.01)
Priority
EP 21172232 05.05.2021
PCT application
PCT/EP2022/053113 09.02.2022
PCT publication
WO2022/233468 10.11.2022
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 1, 2026

    Change

    Published in Swissreg on 01.03.2026

  2. Mar 1, 2025

    Change

    Published in Swissreg on 01.03.2025

  3. Nov 6, 2024

    Change

    Published in Swissreg on 06.11.2024

  4. Jan 26, 2024

    Agent entered

    Representative
    Schaad Balass Menzl & Partner AG Patent- und Markenanwälte, Bellerivestrasse 20, 8034 Zürich

    Published in Swissreg on 26.01.2024

  5. Dec 27, 2023

    Granted

    Published in Swissreg on 27.12.2023

Parties

Holder

Sodha Pharma Consulting GmbH

Finkenstrasse 11, 4104 Oberwil

Agent

Schaad, Balass, Menzl & Partner AG

Schaad Balass Menzl & Partner AG Patent- und Markenanwälte

Bellerivestrasse 20, 8034 Zürich

Inventor

RAVINDRAKUMAR JIVAN, Sodha

4104 Oberwil

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.